Bend Research extends 3-year contract with Bristol-Myers Squibb Bend Research Inc.

, a worldwide biopharmaceutical company. Beneath the conditions of the 3-12 months agreement, Bristol-Myers Squibb use Bend Research’s formulation advancement and manufacturing providers for preclinical and medical development. Bend Research may also manufacture drug item intermediates and drug items in its current Great Manufacturing Practice service for Bristol-Myers Squibb medical trials. In the collaboration, both companies use their complementary fundamental scientific capabilities to resolve complex process-advancement and formulation challenges. ‘We have become excited to increase our working contract with Bristol-Myers Squibb also to combine the data and connection with our two businesses,’ stated Rod Ray, Bend Analysis CEO. ‘We talk about a committed action to applying fundamental research and engineering to the delivery of fresh medicines that may enhance patients’ lives.One of these is Maintenance Choice, a program that allows customers to pick-up 90 time prescriptions at mail order costs whether they are shopping at retail or getting medications through the mail. Foulkes said CVS Caremark is usually expanding MinuteClinic also, the country’s largest retail clinic recognized as a disruptive technology in health care, since it offers convenient quality care at a fraction of the price patients pay in various other healthcare settings.